GLP-1R Signaling and Functional Molecules in Incretin Therapy.

Wan, Wenwei; Qin, Qikai; Xie, Linshan; Zhang, Hanqing; Wu, Fan; Stevens, Raymond C; Liu, Yan

Wan, Wenwei; Qin, Qikai; Xie, Linshan; Zhang, Hanqing; Wu, Fan; Stevens, Raymond C; Liu, Yan.

Afiliação

Wan W; iHuman Institute, ShanghaiTech University, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Qin Q; iHuman Institute, ShanghaiTech University, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Xie L; iHuman Institute, ShanghaiTech University, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Zhang H; iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
Wu F; Structure Therapeutics, South San Francisco, CA 94080, USA.
Stevens RC; iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
Liu Y; Structure Therapeutics, South San Francisco, CA 94080, USA.

Molecules ; 28(2)2023 Jan 11.

Article em En | MEDLINE | ID: mdl-36677809

Assuntos

Diabetes Mellitus Tipo 2; Incretinas; Humanos; Incretinas/uso terapêutico; Diabetes Mellitus Tipo 2/tratamento farmacológico; Diabetes Mellitus Tipo 2/metabolismo; Receptor do Peptídeo Semelhante ao Glucagon 1/metabolismo; Insulina/metabolismo; Transdução de Sinais

Palavras-chave

GLP-1R signaling; drug discovery; functional molecules; incretin therapy; type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Incretinas Limite: Humans Idioma: En Revista: Molecules Assunto da revista: BIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google